141 related articles for article (PubMed ID: 34342490)
21. Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients.
Yu I; Chen L; Ruan JY; Chang JT; Cheung WY
Support Care Cancer; 2016 Mar; 24(3):1199-208. PubMed ID: 26286113
[TBL] [Abstract][Full Text] [Related]
22. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C; Antoniotti C; Rossini D; Lonardi S; Loupakis F; Pietrantonio F; Bordonaro R; Latiano TP; Tamburini E; Santini D; Passardi A; Marmorino F; Grande R; Aprile G; Zaniboni A; Murgioni S; Granetto C; Buonadonna A; Moretto R; Corallo S; Cordio S; Antonuzzo L; Tomasello G; Masi G; Ronzoni M; Di Donato S; Carlomagno C; Clavarezza M; Ritorto G; Mambrini A; Roselli M; Cupini S; Mammoliti S; Fenocchio E; Corgna E; Zagonel V; Fontanini G; Ugolini C; Boni L; Falcone A;
Lancet Oncol; 2020 Apr; 21(4):497-507. PubMed ID: 32164906
[TBL] [Abstract][Full Text] [Related]
23. Bevacizumab safety in Japanese patients with colorectal cancer.
Hatake K; Doi T; Uetake H; Takahashi Y; Ishihara Y; Shirao K
Jpn J Clin Oncol; 2016 Mar; 46(3):234-40. PubMed ID: 26774113
[TBL] [Abstract][Full Text] [Related]
24. Elevated Venous Thromboembolism Risk Following Colectomy for IBD Is Equal to Those for Colorectal Cancer for Ninety Days After Surgery.
Ali F; Al-Kindi SG; Blank JJ; Peterson CY; Ludwig KA; Ridolfi TJ
Dis Colon Rectum; 2018 Mar; 61(3):375-381. PubMed ID: 29420429
[TBL] [Abstract][Full Text] [Related]
25. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB; Mulkerin DL; Mayer RJ; Blanke C
JAMA; 2017 Jun; 317(23):2392-2401. PubMed ID: 28632865
[TBL] [Abstract][Full Text] [Related]
26. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.
Hansson PO; Sörbo J; Eriksson H
Arch Intern Med; 2000 Mar; 160(6):769-74. PubMed ID: 10737276
[TBL] [Abstract][Full Text] [Related]
27. Utilization of bevacizumab in US elderly patients with colorectal cancer receiving chemotherapy.
Fu AZ; Tsai HT; Marshall JL; Freedman AN; Potosky AL
J Oncol Pharm Pract; 2014 Oct; 20(5):332-40. PubMed ID: 24122849
[TBL] [Abstract][Full Text] [Related]
28. Adverse events associated with bevacizumab and chemotherapy in older patients with metastatic colorectal cancer.
Shankaran V; Mummy D; Koepl L; Blough D; Yim YM; Yu E; Ramsey S
Clin Colorectal Cancer; 2013 Sep; 12(3):204-213.e1. PubMed ID: 23276520
[TBL] [Abstract][Full Text] [Related]
29. Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study.
Yoo J; Jeon J; Baik M; Kim J
Thromb Res; 2024 Mar; 235():32-40. PubMed ID: 38295599
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
Kozloff MF; Berlin J; Flynn PJ; Kabbinavar F; Ashby M; Dong W; Sing AP; Grothey A
Oncology; 2010; 78(5-6):329-39. PubMed ID: 20733336
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis.
Alhassan N; Trepanier M; Sabapathy C; Chaudhury P; Liberman AS; Charlebois P; Stein BL; Lee L
Tech Coloproctol; 2018 Dec; 22(12):955-964. PubMed ID: 30569263
[TBL] [Abstract][Full Text] [Related]
32. Incidence and risk factors of venous thromboembolic events in lymphoma.
Zhou X; Teegala S; Huen A; Ji Y; Fayad L; Hagemeister FB; Gladish G; Vadhan-Raj S
Am J Med; 2010 Oct; 123(10):935-41. PubMed ID: 20920696
[TBL] [Abstract][Full Text] [Related]
33. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer.
Akun E; Okutur K; Seber S; Korkmaz T; Aydin K; Bozkurt M; Namal E; Hasbal B; Tecimer C; Demir G
J BUON; 2012; 17(4):669-76. PubMed ID: 23335523
[TBL] [Abstract][Full Text] [Related]
35. The importance of extended postoperative venous thromboembolism prophylaxis in IBD: a National Surgical Quality Improvement Program analysis.
Gross ME; Vogler SA; Mone MC; Sheng X; Sklow B
Dis Colon Rectum; 2014 Apr; 57(4):482-9. PubMed ID: 24608305
[TBL] [Abstract][Full Text] [Related]
36. A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer.
Chen Y; Wang Y; Xie S; Zheng H; Tong Y; Gao X; Lu R; Guo L
Clin Appl Thromb Hemost; 2021; 27():10760296211064900. PubMed ID: 34859707
[TBL] [Abstract][Full Text] [Related]
37. How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database.
Fleming FJ; Kim MJ; Salloum RM; Young KC; Monson JR
Dis Colon Rectum; 2010 Oct; 53(10):1355-60. PubMed ID: 20847615
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience.
Nobili E; Di Cicilia R; Di Battista M; Morselli-Labate AM; Paragona M; Corbelli J; Macchini M; Prandoni P; Biasco G; Brandi G
Pathophysiol Haemost Thromb; 2010; 37(1):30-4. PubMed ID: 20956868
[TBL] [Abstract][Full Text] [Related]
39. Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab.
Kuk A; Magnowska M; Suchy W; Swierczynska J; Zaborowski MP; Gaca M; Nowak-Markwitz E
Target Oncol; 2017 Aug; 12(4):495-503. PubMed ID: 28580507
[TBL] [Abstract][Full Text] [Related]
40. Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapporo CAT study).
Aonuma AO; Nakamura M; Sakamaki K; Murai T; Matsuda C; Itaya K; Sone T; Yagisawa M; Koike Y; Endo A; Tsukuda Y; Ono Y; Nagasaka A; Nishikawa S; Yamanaka T; Sakamoto N
BMJ Open; 2019 Aug; 9(8):e028563. PubMed ID: 31439602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
